According to CASI Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -โน2.26 B. In 2023 the company made an earning of -โน2.22 B an increase over its 2022 earnings that were of -โน3.15 B.The earnings displayed on this page is the company's Pretax Income.